211 related articles for article (PubMed ID: 15304390)
1. BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks.
Nowicki MO; Falinski R; Koptyra M; Slupianek A; Stoklosa T; Gloc E; Nieborowska-Skorska M; Blasiak J; Skorski T
Blood; 2004 Dec; 104(12):3746-53. PubMed ID: 15304390
[TBL] [Abstract][Full Text] [Related]
2. BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells.
Slupianek A; Nowicki MO; Koptyra M; Skorski T
DNA Repair (Amst); 2006 Feb; 5(2):243-50. PubMed ID: 16297667
[TBL] [Abstract][Full Text] [Related]
3. BCR/ABL stimulates WRN to promote survival and genomic instability.
Slupianek A; Poplawski T; Jozwiakowski SK; Cramer K; Pytel D; Stoczynska E; Nowicki MO; Blasiak J; Skorski T
Cancer Res; 2011 Feb; 71(3):842-51. PubMed ID: 21123451
[TBL] [Abstract][Full Text] [Related]
4. BCR/ABL downregulates DNA-PK(CS)-dependent and upregulates backup non-homologous end joining in leukemic cells.
Poplawski T; Blasiak J
Mol Biol Rep; 2010 Jun; 37(5):2309-15. PubMed ID: 19697154
[TBL] [Abstract][Full Text] [Related]
5. ATR-Chk1 axis protects BCR/ABL leukemia cells from the lethal effect of DNA double-strand breaks.
Nieborowska-Skorska M; Stoklosa T; Datta M; Czechowska A; Rink L; Slupianek A; Koptyra M; Seferynska I; Krszyna K; Blasiak J; Skorski T
Cell Cycle; 2006 May; 5(9):994-1000. PubMed ID: 16687921
[TBL] [Abstract][Full Text] [Related]
6. BCR/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair.
Cramer K; Nieborowska-Skorska M; Koptyra M; Slupianek A; Penserga ET; Eaves CJ; Aulitzky W; Skorski T
Cancer Res; 2008 Sep; 68(17):6884-8. PubMed ID: 18757400
[TBL] [Abstract][Full Text] [Related]
7. BCR/ABL, DNA damage and DNA repair: implications for new treatment concepts.
Skorski T
Leuk Lymphoma; 2008 Apr; 49(4):610-4. PubMed ID: 18398719
[TBL] [Abstract][Full Text] [Related]
8. Does the bcr/abl-mediated increase in the efficacy of DNA repair play a role in the drug resistance of cancer cells?
Majsterek I; Blasiak J; Mlynarski W; Hoser G; Skórski T
Cell Biol Int; 2002; 26(4):363-70. PubMed ID: 11991666
[TBL] [Abstract][Full Text] [Related]
9. Non-homologous DNA end joining repair in normal and leukemic cells depends on the substrate ends.
Pastwa E; Poplawski T; Czechowska A; Malinowski M; Blasiak J
Z Naturforsch C J Biosci; 2005; 60(5-6):493-500. PubMed ID: 16042351
[TBL] [Abstract][Full Text] [Related]
10. Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair.
Sallmyr A; Fan J; Rassool FV
Cancer Lett; 2008 Oct; 270(1):1-9. PubMed ID: 18467025
[TBL] [Abstract][Full Text] [Related]
11. DNA Repair--A Double-Edged Sword in the Genomic Stability of Cancer Cells--The Case of Chronic Myeloid Leukemia.
Pawlowska E; Blasiak J
Int J Mol Sci; 2015 Nov; 16(11):27535-49. PubMed ID: 26593906
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks.
Sallmyr A; Tomkinson AE; Rassool FV
Blood; 2008 Aug; 112(4):1413-23. PubMed ID: 18524993
[TBL] [Abstract][Full Text] [Related]
13. Imatinib (STI571) induces DNA damage in BCR/ABL-expressing leukemic cells but not in normal lymphocytes.
Czechowska A; Poplawski T; Drzewoski J; Blasiak J
Chem Biol Interact; 2005 Apr; 152(2-3):139-50. PubMed ID: 15840387
[TBL] [Abstract][Full Text] [Related]
14. Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination.
Yang S; Chintapalli J; Sodagum L; Baskin S; Malhotra A; Reiss K; Meggs LG
Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1144-52. PubMed ID: 15956778
[TBL] [Abstract][Full Text] [Related]
15. BCR-ABL stimulates mutagenic homologous DNA double-strand break repair via the DNA-end-processing factor CtIP.
Salles D; Mencalha AL; Ireno IC; Wiesmüller L; Abdelhay E
Carcinogenesis; 2011 Jan; 32(1):27-34. PubMed ID: 20974687
[TBL] [Abstract][Full Text] [Related]
16. BCR-ABL1 kinase facilitates localization of acetylated histones 3 and 4 on DNA double-strand breaks.
Falinski R; Nieborowska-Skorska M; Skorski T
Leuk Res; 2012 Feb; 36(2):241-4. PubMed ID: 22036635
[TBL] [Abstract][Full Text] [Related]
17. BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatin.
Slupianek A; Gurdek E; Koptyra M; Nowicki MO; Siddiqui KM; Groden J; Skorski T
Oncogene; 2005 Jun; 24(24):3914-22. PubMed ID: 15750625
[TBL] [Abstract][Full Text] [Related]
18. Leukemia patient-derived lymphoblastoid cell lines exhibit increased induction of leukemia-associated transcripts following high-dose irradiation.
Spencer A; Granter N
Exp Hematol; 1999 Sep; 27(9):1397-401. PubMed ID: 10480430
[TBL] [Abstract][Full Text] [Related]
19. ABL-fusion oncoproteins activate multi-pathway of DNA repair: role in drug resistance?
Majsterek I; Slupianek A; Hoser G; Skórski T; Blasiak J
Biochimie; 2004 Jan; 86(1):53-65. PubMed ID: 14987801
[TBL] [Abstract][Full Text] [Related]
20. BCR/ABL induces chromosomal instability after genotoxic stress and alters the cell death threshold.
Dierov J; Sanchez PV; Burke BA; Padilla-Nash H; Putt ME; Ried T; Carroll M
Leukemia; 2009 Feb; 23(2):279-86. PubMed ID: 19020542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
